MeSH term
Count | Drug Evaluation, Preclinical | 174 |
*Drug Evaluation, Preclinical | 10 |
Drug Evaluation, Preclinical/trends | 10 |
Drug Evaluation, Preclinical/*methods | 31 |
Drug Evaluation, Preclinical/standards | 1 |
Drug Evaluation, Preclinical/methods | 32 |
Drug Evaluation, Preclinical/methods/*trends | 1 |
Drug Evaluation, Preclinical/*instrumentation/methods | 1 |
Drug Evaluation, Preclinical/instrumentation/methods | 1 |
Drug Evaluation, Preclinical/methods/statistics & numerical data | 2 |
Drug Evaluation | 249 |
*Drug Evaluation | 1 |
Drug Evaluation/*methods | 3 |
Drug Evaluation/methods | 3 |
Drug Evaluation/methods/statistics & numerical data | 1 |
Program Evaluation | 41 |
*Program Evaluation | 3 |
Evaluation Studies | 682 |
Disability Evaluation | 36 |
*Disability Evaluation | 10 |
*Work Capacity Evaluation | 2 |
Nursing Evaluation Research | 7 |
Program Evaluation/*economics | 1 |
Work Capacity Evaluation | 1 |
Program Evaluation/*statistics & numerical data | 1 |
Drug Resistance, Neoplasm/drug effects/genetics/*physiology | 2 |
Dyskinesia, Drug-Induced/diagnosis/drug therapy/*physiopathology | 1 |
Dyskinesia, Drug-Induced/drug therapy/etiology/*physiopathology | 1 |
Dyskinesia, Drug-Induced/complications/*drug therapy/metabolism | 1 |
Drug Resistance, Neoplasm/drug effects/*genetics | 1 |
Drug Resistance, Multiple/*drug effects/genetics | 2 |
Receptors, Drug/analysis/drug effects/*physiology | 1 |
Drug Resistance, Neoplasm/drug effects/physiology | 1 |
Drug Resistance, Multiple/*drug effects/physiology | 1 |
Receptors, Drug/drug effects/genetics/*metabolism | 1 |
Drug Resistance, Viral/drug effects/genetics | 1 |
Drug Resistance, Neoplasm/drug effects/genetics | 1 |
Abnormalities, Drug-Induced/drug therapy/physiopathology | 1 |
Drug Resistance, Neoplasm/drug effects/*physiology | 1 |
Drug Resistance, Multiple/drug effects/*physiology | 1 |
Drug Resistance, Multiple, Viral/*drug effects | 1 |
Drug Resistance, Neoplasm/*drug effects/genetics | 3 |
Receptors, Drug/drug effects/metabolism/*physiology | 1 |
Receptors, Drug/*deficiency/*drug effects/genetics | 1 |
*Drug Resistance, Neoplasm/drug effects | 1 |
Drug Hypersensitivity/*drug therapy/metabolism | 1 |
Receptors, Drug/drug effects/metabolism | 2 |
Drug Resistance/drug effects/*physiology | 1 |
Drug Resistance, Neoplasm/drug effects | 3 |
Drug Resistance, Multiple/*drug effects | 5 |
Drug Resistance, Neoplasm/*drug effects | 7 |
Dyskinesia, Drug-Induced/drug therapy | 1 |
Receptors, Drug/*drug effects/metabolism | 2 |
Drug Resistance, Multiple/drug effects | 2 |
Dyskinesia, Drug-Induced/*drug therapy | 1 |
Receptors, Drug/classification/*drug effects | 1 |
Receptors, Drug/drug effects/*metabolism | 3 |
Receptors, Drug/drug effects/*physiology | 1 |
Receptors, Drug/drug effects | 3 |
*Receptors, Drug/drug effects | 1 |
Drug Resistance/*drug effects | 1 |
Drug Tolerance/drug effects | 1 |
Drug Resistance/drug effects | 1 |
Receptors, Drug/*drug effects | 4 |
*Drug Combinations | 3 |
Drug Tolerance | 120 |
HIV-2/drug effects | 5 |
*Drug Costs | 3 |
*Drug Tolerance | 2 |
Drug Resistance | 601 |
HIV-1/*drug effects | 137 |
Drug Costs | 16 |
Drug Storage | 6 |
Drug Synergism | 1355 |
*HIV-1/drug effects | 12 |
Drug Stability | 213 |
Drug Antagonism | 46 |
*Drug Stability | 1 |
Drug Monitoring | 46 |
Instillation, Drug | 6 |
Eye/drug effects | 5 |
Drug Design | 303 |
Drug Utilization | 11 |
*Drug Carriers | 5 |
*Drug Contamination | 7 |
*Drug Interactions | 23 |
Legislation, Drug | 5 |
DNA/drug effects | 22 |
Drug Therapy | 14 |
*Instillation, Drug | 2 |
Drug Implants | 40 |
HIV-1/drug effects | 41 |
HIV-2/*drug effects | 2 |
Drug Residues | 1 |
Drug Approval | 2 |
Drug Hypersensitivity | 7 |
Drug Toxicity | 3 |
*Drug Hypersensitivity | 4 |
*Drug Eruptions | 1 |
Drug Combinations | 529 |
